Clinical trial
Phase II Study of JNS024PR in Cancer Pain Patients
NCT00805142 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of JNS024PR in Cancer Pain Patients
- Lead sponsor
- Janssen Pharmaceutical K.K.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- July 31, 2009
- Enrollment
- 78 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, pain